Similar articles

• Sulphinpyrazone and warfarin after myocardial infarction.

  Tulloch JA, Marr TC. Tulloch JA, et al. Br Med J. 1979 Jul 14;2(6182):133. doi: 10.1136/bmj.2.6182.133. Br Med J. 1979. PMID: 466316 Free PMC article. No abstract available.
• Sulphinpyrazone (Anturan) after myocardial infarction.

  Nicholson MR, Whitlock RM. Nicholson MR, et al. N Z Med J. 1979 Sep 26;90(644):263. N Z Med J. 1979. PMID: 390442 Clinical Trial. No abstract available.
• Sulphinpyrazone after myocardial infarction.

  Weston MJ. Weston MJ. Lancet. 1978 Apr 8;1(8067):766-7. doi: 10.1016/s0140-6736(78)90875-9. Lancet. 1978. PMID: 76764 No abstract available.
• Antiplatelet and anticoagulant therapy in acute myocardial infarction.

  Jafri SM. Jafri SM. Henry Ford Hosp Med J. 1991;39(3-4):195-9. Henry Ford Hosp Med J. 1991. PMID: 1804824 Review. No abstract available.
• [Myocardial infarct: secondary prevention with drugs and their effects].

  Kanazawa T, Matsuoka H. Kanazawa T, et al. Nihon Rinsho. 1980 Oct;38(10):4097-105. Nihon Rinsho. 1980. PMID: 7019479 Review. Japanese. No abstract available.